KP Wellness
9:12 AM - Public
FDA NEWS RELEASE
FDA approves Belviq to treat some overweight or obese adults
The U.S. Food and Drug Administration today approved Belviq (lorcaserin hydrochloride), as an addition to a reduced-calorie diet and exercise, for chronic weight management.
The drug is approved for use in adults with a body mass index (BMI) of 30 or greater (obese), or adults with a BMI of 27 or greater (overweight) and who have at least one weight-related condition such as high blood pressure (hypertension), type 2 diabetes, or high cholesterol (dyslipidemia).
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm309993.htm
FDA approves Belviq to treat some overweight or obese adults
The U.S. Food and Drug Administration today approved Belviq (lorcaserin hydrochloride), as an addition to a reduced-calorie diet and exercise, for chronic weight management.
The drug is approved for use in adults with a body mass index (BMI) of 30 or greater (obese), or adults with a BMI of 27 or greater (overweight) and who have at least one weight-related condition such as high blood pressure (hypertension), type 2 diabetes, or high cholesterol (dyslipidemia).
http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm309993.htm
KP Wellness
9:11 AM - Public
Belviq: 5 Things You Need to Know About the New Weight-Loss Pill
With the first new weight-loss drug to be approved in 13 years, dieters now have a new weapon against obesity. Is it for you?
Read more: http://healthland.time.com/2012/06/28/belviq-5-things-you-need-to-know-about-the-new-diet-pill/
With the first new weight-loss drug to be approved in 13 years, dieters now have a new weapon against obesity. Is it for you?
Read more: http://healthland.time.com/2012/06/28/belviq-5-things-you-need-to-know-about-the-new-diet-pill/
KP Wellness
Yesterday 6:46 AM - Public
(Reuters) - U.S. health regulators approved the first new weight-loss drug in 13 years, allowing Arena Pharmaceuticals Inc to bring its Belviq pill to market as public health advocates push for new solutions to the nation's growing obesity epidemic.
Belviq, known chemically as lorcaserin, was one of three experimental weight-loss treatments seeking FDA approval after initial rejections by the agency. Vivus Inc and Orexigen Therapeutics Inc are still hoping to bring their medicines to market.
Belviq is designed to block appetite signals in the brain to help people feel full after eating smaller amounts of food. In large clinical trials, patients on average lost about 5 percent of body weight. The drug's FDA-approved label says Belviq use should be stopped if a patient has not reached 5 percent weight loss after 12 weeks of daily use.
The Arena drug is approved for use in adults with a body mass index (BMI) of 30 or greater, which is considered obese, or adults with a BMI of 27 or greater -- overweight -- who have at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol. BMI is a measure of body fat relative to a person's height and weight.
http://www.reuters.com/article/2012/06/27/us-arena-obesity-idUSBRE85Q1AA20120627
Belviq, known chemically as lorcaserin, was one of three experimental weight-loss treatments seeking FDA approval after initial rejections by the agency. Vivus Inc and Orexigen Therapeutics Inc are still hoping to bring their medicines to market.
Belviq is designed to block appetite signals in the brain to help people feel full after eating smaller amounts of food. In large clinical trials, patients on average lost about 5 percent of body weight. The drug's FDA-approved label says Belviq use should be stopped if a patient has not reached 5 percent weight loss after 12 weeks of daily use.
The Arena drug is approved for use in adults with a body mass index (BMI) of 30 or greater, which is considered obese, or adults with a BMI of 27 or greater -- overweight -- who have at least one weight-related health condition, such as high blood pressure, type 2 diabetes, or high cholesterol. BMI is a measure of body fat relative to a person's height and weight.
http://www.reuters.com/article/2012/06/27/us-arena-obesity-idUSBRE85Q1AA20120627
KP Wellness
7:49 AM - Public
washing hands with soap and water could reduce diarrheal disease-associated deaths by up to 50%
Hundreds of thousands of persons in the U.K. (between 1.2% and 1.3% of the total population) acquire outer ear infections each year, due to contaminated water remaining in the ear after swimming or bathing
Hundreds of thousands of persons in the U.K. (between 1.2% and 1.3% of the total population) acquire outer ear infections each year, due to contaminated water remaining in the ear after swimming or bathing
Can washing hands save lives?
Researchers in London estimate that if everyone routinely washed their hands, a million deaths a year could be prevented. Read more about that fact and other hygene fact facts from the Centers for Disease Control:
http://www.cdc.gov/healthywater/hygiene/fast_facts.html
Researchers in London estimate that if everyone routinely washed their hands, a million deaths a year could be prevented. Read more about that fact and other hygene fact facts from the Centers for Disease Control:
http://www.cdc.gov/healthywater/hygiene/fast_facts.html
KP Wellness
7:47 AM - Public
KP Wellness
7:39 AM - Public
try the Coconut Oil. I took 3 tablespoons a day and within two months, I returned to my physician and she just couldn’t believe that EVERYTHING on my tests was once again normal!
Read how Coconut Oil Benefits those with Hypothyroidism!
KP Wellness
Yesterday 8:13 PM - Public
via +Cheryl Ann MacDonald, Psy'D.
Dr Arya Sharma and Dr Jacqui Gingras debate whether obesity should be viewed as a disease in Ottawa, Ontario on June 7, 2012.
Is Obesity A Disease?
Dr Arya Sharma and Dr Jacqui Gingras debate whether obesity should be viewed as a disease in Ottawa, Ontario on June 7, 2012.
Is Obesity A Disease?
No comments:
Post a Comment